Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemic
- PMID: 35108126
- PMCID: PMC8814611
- DOI: 10.1177/1357633X211073428
Changes in telemedicine use and ambulatory visit volumes at a multispecialty cardiovascular center during the COVID-19 pandemic
Abstract
Early in the COVID-19 pandemic, cardiology clinics rapidly implemented telemedicine to maintain access to care. Little is known about subsequent trends in telemedicine use and visit volumes across cardiology subspecialties. We conducted a retrospective cohort study including all patients with ambulatory visits at a multispecialty cardiovascular center in Northern California from March 2019 to February 2020 (pre-COVID) and March 2020 to February 2021 (COVID). Telemedicine use increased from 3.5% of visits (1200/33,976) during the pre-COVID period to 63.0% (21,251/33,706) during the COVID period. Visit volumes were below pre-COVID levels from March to May 2020 but exceeded pre-COVID levels after June 2020, including when local COVID-19 cases peaked. Telemedicine use was above 75% of visits in all cardiology subspecialties in April 2020 and stabilized at rates ranging from over 95% in electrophysiology to under 25% in heart transplant and vascular medicine. From June 2020 to February 2021, subspecialties delivering a greater percentage of visits through telemedicine experienced larger increases in new patient visits (r = 0.81, p = 0.029). Telemedicine can be used to deliver a significant proportion of outpatient cardiovascular care though utilization varies across subspecialties. Higher rates of telemedicine adoption may increase access to care in cardiology clinics.
Keywords: COVID-19; Telecardiology; cardiovascular disease; telehealth; telemedicine.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: FR reports consulting fees from Novartis, Janssen, NovoNordisk, and HealthPals outside the submitted work. RD reports research funding from Bayer AG and consulting fees from HealthPals outside the submitted work.
Figures


References
-
- Hollander JE, Carr BG. Virtually perfect? Telemedicine for covid-19. N Engl J Med 2020; 382: 1679–1681. - PubMed
-
- Artandi M, Thomas S, Shah NR, et al. Rapid system transformation to more than 75% primary care video visits within three weeks at Stanford: Response to Public Safety Crisis during a pandemic. NEJM Catalyst 2020 April 21, https://catalystnejm.org/doi/full/10.1056/CAT.20.0100 (2020, accessed 11 August 2020). - DOI
-
- Verma S. Early impact of CMS expansion of Medicare telehealth during COVID-19. Health Affairs Blog, 2020. July 15, https://www.healthaffairs.org/do/10.1377/forefront.20200715.454789/abs/. - DOI
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous